Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Accepted: 18 October 2022
First Online: 16 November 2022
Declarations
:
: Dr. Fritsch and Dr. Rangus have no conflicts of interest. Dr. Nolte reports personal fees from Boehringer Ingelheim, personal fees from Bayer Pharma, personal fees from Daichii Sankyo, personal fees from Alexion, personal fees from Bristol-Myers Squibb, personal fees from Abbott, personal fees from Takeda, personal fees from Pfizer, grants from German Ministry of Research and Education, grants from German Center for cardiovascular Research, grants from German Center for Neurodegenerative Diseases, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.